{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:31:54Z","timestamp":1764714714028},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.semarthrit.2015.02.005","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:39:48Z","timestamp":1424392788000},"page":"67-69","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Rituximab for remission induction in elderly patients with ANCA-associated vasculitis"],"prefix":"10.1016","volume":"45","author":[{"given":"H.","family":"Timlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Manno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duvura","family":"Geetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2015.02.005_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00002281-200101000-00008","article-title":"Update on the European Vasculitis Study Group trials","volume":"13","author":"Jayne","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib3","doi-asserted-by":"crossref","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, et al. Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis, 69:1036-1043.","DOI":"10.1136\/ard.2009.109389"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib5","doi-asserted-by":"crossref","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med, 363:221-232.","DOI":"10.1056\/NEJMoa0909905"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib6","doi-asserted-by":"crossref","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med, 363:211-220.","DOI":"10.1056\/NEJMoa0909169"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000072990","article-title":"Current attitudes to the therapy of vasculitis","volume":"26","author":"Jayne","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.2010.489","article-title":"ANCA-associated glomerulonephritis in the very elderly","volume":"79","author":"Bomback","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib9","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","article-title":"Antiproteinase 3- and antimyeloperoxidase-associated vasculitis","volume":"57","author":"Franssen","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib10","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s11255-014-0717-y","article-title":"Clinical outcomes of ANCA-associated vasculitis in elderly patients","volume":"46","author":"Haris","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/rheumatology\/keh522","article-title":"ANCA-associated renal vasculitis at the end of the twentieth century\u2014a disease of older patients","volume":"44","author":"Harper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.rdc.2010.04.002","article-title":"Epidemiology of ANCA-associated vasculitis","volume":"36","author":"Ntatsaki","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/RHU.0b013e31816b2fbd","article-title":"ANCA vasculitis in the elderly","volume":"14","author":"Hoganson","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2015.02.005_bib14","unstructured":"CDC: The state of aging and health in America; 2013. \u3008http:\/\/www.cdc.gov\/aging\/pdf\/state-aging-health-in-america-2013.pdf\u3009."},{"key":"10.1016\/j.semarthrit.2015.02.005_bib15","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017215000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T20:57:09Z","timestamp":1537822629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017215000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0049017215000153"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.02.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab for remission induction in elderly patients with ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2015.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}